Mr. Speaker, let me reassure the hon. member and everyone in the House that we take very seriously our regulatory obligations in post-marketing surveillance of drugs in relation to their safety and efficacy.
Obviously the Vanessa Young situation was a terrible tragedy. My department, Health Canada, is responding to the 14 recommendations of the coroner's inquest. As Dr. Peterson who heads up the drug approval agency in my department mentioned earlier today, as of April 1 we will create a new directorate in the Department of Health to ensure that--